Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of 12-Week Freestyle Libre 2.0 in Children with Type 1 Diabetes and Elevated HbA1c: A Multicenter Randomized Controlled Trial.
Jefferies CA, Boucsein A, Styles SE, Chamberlain B, Michaels VR, Crockett HR, De Lange M, Lala A, Cunningham V, Wiltshire EJ, Serlachius AS, Wheeler BJ. Jefferies CA, et al. Among authors: boucsein a. Diabetes Technol Ther. 2023 Dec;25(12):827-835. doi: 10.1089/dia.2023.0292. Epub 2023 Oct 20. Diabetes Technol Ther. 2023. PMID: 37782139 Free PMC article. Clinical Trial.
A comparison of FreeStyle Libre 2 to self-monitoring of blood glucose in children with type 1 diabetes and sub-optimal glycaemic control: a 12-week randomised controlled trial protocol.
Styles S, Wheeler B, Boucsein A, Crocket H, de Lange M, Signal D, Wiltshire E, Cunningham V, Lala A, Cutfield W, de Bock M, Serlachius A, Jefferies C. Styles S, et al. Among authors: boucsein a. J Diabetes Metab Disord. 2021 Oct 5;20(2):2093-2101. doi: 10.1007/s40200-021-00907-y. eCollection 2021 Dec. J Diabetes Metab Disord. 2021. PMID: 34900845 Free PMC article.
Study protocol: Safety and efficacy of smart watch integrated do-it-yourself continuous glucose monitoring in adults with Type 1 diabetes, a randomised controlled trial.
Sehgal S, De Bock M, Williman J, Taylor B, Elbalshy M, Galland B, Hall R, Paul R, Boucsein A, Jones S, Frewen C, Wheeler BJ. Sehgal S, et al. Among authors: boucsein a. J Diabetes Metab Disord. 2021 Oct 31;20(2):2103-2113. doi: 10.1007/s40200-021-00923-y. eCollection 2021 Dec. J Diabetes Metab Disord. 2021. PMID: 34900846 Free PMC article.
Glucose and Psychosocial Outcomes 12 Months Following Transition from Multiple Daily Injections to Advanced Hybrid Closed Loop in Youth with Type 1 Diabetes and Suboptimal Glycemia.
Michaels VR, Boucsein A, Watson AS, Frewen CM, Sanders OJ, Haszard JJ, Jones SD, Milford-Hughes PJ, de Bock MI, Wheeler BJ. Michaels VR, et al. Among authors: boucsein a. Diabetes Technol Ther. 2024 Jan;26(1):40-48. doi: 10.1089/dia.2023.0334. Epub 2023 Nov 7. Diabetes Technol Ther. 2024. PMID: 37823890
Associations between type 1 diabetes and educational outcomes: an Aotearoa/New Zealand nationwide birth cohort study using the Integrated Data Infrastructure.
Bowden N, Dixon R, Anderson V, de Bock M, Boucsein A, Kewene-Edwards M, Gibb S, Kokaua J, Palmer O, Paul R, Taylor B, Vu H, Wheeler BJ. Bowden N, et al. Among authors: boucsein a. Diabetologia. 2024 Jan;67(1):62-73. doi: 10.1007/s00125-023-06026-y. Epub 2023 Oct 23. Diabetologia. 2024. PMID: 37870651 Free PMC article.
Study protocol: glycaemic outcomes in people with type 2 diabetes initiating continuous glucose monitoring: the 2GO-CGM study.
Lever CS, Williman JA, Boucsein A, Watson A, Sampson RS, Sergel-Stringer OT, Keesing C, Chepulis L, Wheeler BJ, de Bock MI, Paul RG. Lever CS, et al. Among authors: boucsein a. J Diabetes Metab Disord. 2023 Jun 15;22(2):1779-1792. doi: 10.1007/s40200-023-01244-y. eCollection 2023 Dec. J Diabetes Metab Disord. 2023. PMID: 37969919 Free PMC article.
16 results